Juan Andres - Oct 15, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Technical Operations and Quality Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Oct 15, 2021
Transactions value $
-$3,195,450
Form type
4
Date filed
10/19/2021, 04:11 PM
Previous filing
Oct 14, 2021
Next filing
Oct 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $61.1K +5K $12.21* 5K Oct 15, 2021 Direct F1
transaction MRNA Common Stock Sale -$1.71M -5K -100% $341.25 0 Oct 15, 2021 Direct F1
transaction MRNA Common Stock Options Exercise $61.1K +5K $12.21* 5K Oct 18, 2021 Direct F1
transaction MRNA Common Stock Sale -$1.61M -5K -100% $322.26 0 Oct 18, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -5K -2.78% $0.00 175K Oct 15, 2021 Common Stock 5K $12.21 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -5K -2.86% $0.00 170K Oct 18, 2021 Common Stock 5K $12.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020, and amended on May 12, 2021.
F2 This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer